George Havrilla, DPM
Primary Podiatric Medicine · Thomson, GANPI 1306841374
Payments from drug & device makers
What this record shows
16 manufacturers reported payments, led by Triad Life Sciences Inc. at 37.7% of the total. Reporting peaked in 2022 at $1,401 and has fallen 71.0% since, to $406 in 2025.
Across 73 payments — averaging $42.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Triad Life Sciences Inc.$1K
- Organogenesis Inc.$398
- Smith+Nephew$340
- Biotissue Holdings Inc.$239
- Paratek Pharmaceuticals, Inc.$202
- Bioventus LLC$173
- plus $579 from 10 others
What the payments were for
- Travel & lodging$1,40745%
- Food & beverage$1,69155%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Triad Life Sciences Inc. | 1 | $1,168 |
| Organogenesis Inc. | 21 | $398 |
| Smith+Nephew | 17 | $340 |
| Biotissue Holdings Inc. | 1 | $239 |
| Paratek Pharmaceuticals, Inc. | 10 | $202 |
| Bioventus LLC | 9 | $173 |
| Melinta Therapeutics, LLC | 2 | $137 |
| Convatec Inc. | 3 | $115 |
| Innovation Technologies Inc | 1 | $102 |
| Globus Medical | 2 | $84 |
| Johnson & Johnson | 1 | $36 |
| Stryker | 1 | $25 |
| Normatec Industries, LP | 1 | $24 |
| Stability Biologics, LLC | 1 | $21 |
| AbbVie | 1 | $18 |
| ERMI LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$1,168
- Prokera$239
- AmnioGraft$239
- AmnioGuard$239
- Kimyrsa$115
- Irrisept$102
How this compares
Too few primary podiatric medicine providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 110 | $3,302 |
| Mupirocin | 247 | $2,610 |
| CiclopiroxCiclopirox Olamine | 69 | $1,851 |
| Ciclopirox | 22 | $1,024 |
| Doxycycline Hyclate | 52 | $672 |
| SsdSilver Sulfadiazine | 18 | $602 |
| Diclofenac Sodium | 20 | $546 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 11 | $433 |
| Silver Sulfadiazine | 13 | $431 |
| Terbinafine Hcl | 51 | $367 |
| Pregabalin | 25 | $312 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $134 |
| Ciprofloxacin Hcl | 12 | $128 |
| Allopurinol | 29 | $125 |
| Meloxicam | 51 | $113 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Thomson
- Faye-Rose GrebenyukColumbus$3K
- Jimmie FeltonAmericus$1K
- Kent KronowskiAugusta$947
- Mary OttingerAugusta$846
- Rondrick WilliamsonAtlanta$347
- Rose-Mary Mbibong-MaboAtlanta$209
- Charles SidlowCartersville$186
- Claire HollstromLagrange$161
- James DenmarkAugusta$100
- Jacqueline QuinteroDecatur$43
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.